|1||NCT00072046||Completed||Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)||
||Other / NIH||
||732||All||18 Years to 120 Years (Adult, Senior)||NCT00072046||CALGB-90206
|October 2003||January 2004||November 2012||November 6, 2003||July 6, 2016||
|2||NCT01202032||Completed||Multicenter Dose-escalation Study of a Combination of Pazopanib and Bevacizumab in Patients With Metastatic Renal Cell Carcinoma or Others Advanced Solid Tumors||
||36||All||18 Years and older (Adult, Senior)||NCT01202032||PARASOL||PARASOL||July 2010||January 2013||March 2013||September 15, 2010||May 18, 2016||
† Study has passed its completion date and status has not been verified in more than two years.